Printer Friendly
The Free Library
14,715,772 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

About the Drug Fact Sheets.


This issue's drug fact sheets summarize the currently approved drugs indicated for the treatment of HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  infection. The drugs are grouped according to class: nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors Non-Nucleoside Reverse Transcriptase Inhibitors Definition

This type of drug interferes with an enzyme that is key to the replication (reproduction) of the human immunodeficiency virus (HIV).
 (NNRTIs) and protease inhibitors Protease Inhibitors Definition

A protease inhibitor is a type of drug that cripples the enzyme protease. An enzyme is a substance that triggers chemical reactions in the body.
. Within each class, the drugs are listed in the order of approval by the US Food and Drug Administration.

The "Guidelines classification" for each drug refers to that drug's recommended use according to The Panel on Clinical Practices for the Treatment of HIV Infection. This panel was convened in 1996 by the US Department of Health and Human Services Noun 1. Department of Health and Human Services - the United States federal department that administers all federal programs dealing with health and welfare; created in 1979
Health and Human Services, HHS
 and the Henry J. Kaiser Henry John Kaiser (May 9, 1882—August 24, 1967) was an American industrialist who became known as the father of modern American shipbuilding. Early life
Beginning as a cashier in a dry-goods shop in Utica, New York, Kaiser moved many times as he pursued the
 Family Foundation. These guidelines can be downloaded from hivatis.org through the HIV/AIDS HIV/AIDS Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome  Treatment Information Service (ATIS ATIS - A Tools Integration Standard ). Table IX (on page 32 of the guidelines) summarizes the panel's recommendations for the use of these drugs in combination for the treatment of established HIV infection. A treatment regimen is usually comprised of a choice from Column A and a choice from Column B. The table is reproduced below for your convenience.
                                           Column A

Strongly Recommended                       Efavirenz
                                           Indinavir
                                           Nelfinavir
                                           Ritonavir + Saquinavir
                                              (SGC* or HGC*)

                                           Column A

Recommended as an Alternative              Abacavir
                                           Amprenavir
                                           Delavirdine
                                           Nelfinavir +
                                              Saquinavir-SGC
                                           Nevirapine
                                           Ritonavir
                                           Saquinavir-SGC

No Recommendation; Insufficient Data**     Hydroxyurea in
                                            combination with other
                                            antiretroviral drugs
                                           Ritonavir + Indinavir
                                           Ritonavir + Nelfinavir

                                           Column A

Not Recommended; Should Not Be Offered
(All monotherapies, whether from column
A or B***)                                 Saquinavir-HGC****

                                           Column B

Strongly Recommended                       Stavudine + Lamivudine
                                           Stavudine + Didanosine
                                           Zidovudine + Lamivudine
                                           Zidovudine + Didanosine

                                           Column B

Recommended as an Alternative              Didanosine + Lamivudine
                                           Zidovudine + Zalcitabine

Not Recommended; Should Not Be Offered
(All monotherapies, whether from column
A or B***)

                                           Column B

Not Recommended; Should Not Be Offered
(All monotherapies, whether from column
A or B***)                                 Stavudine + Zidovudine
                                           Zalcitabine + Lamivudine
                                           Zalcitabine + Stavudine
                                           Zalcitabine + Didanosine


(*) Saquinavir-SGC, soft-gel capsule (Fortovase): Saquinavir-HGC, hard-gel capsule (Invirase).

(**) This category includes drugs or combinations for which information is too limited to allow a recommendation for or against use.

(***) Zidovudine zidovudine /zi·do·vu·dine/ (zi-do´vu-den) a synthetic nucleoside (thymidine) analogue that inhibits replication of some retroviruses, including the human immunodeficiency virus; used in the treatment of HIV infection and AIDS.  monotherapy may be considered for prophylactic use in pregnant women with low viral load viral load
n.
The concentration of a virus, such as HIV, in the blood.


viral load,
n a measure of the number of virus particles present in the bloodstream, expressed as copies per milliliter.
 and high CD4 T cell Noun 1. CD4 T cell - T cell with CD4 receptor that recognizes antigens on the surface of a virus-infected cell and secretes lymphokines that stimulate B cells and killer T cells; helper T cells are infected and killed by the AIDS virus  counts to prevent perinatal transmission, as discussed under "Considerations in the Pregnant Woman".

**** Use of Saquinavir-HGC (Invirase) is not recommended, except in combination with ritonavir ritonavir /ri·to·na·vir/ (ri-to´nah-vir) an HIV protease inhibitor used in treatment of HIV infection and AIDS.

ri·ton·a·vir
n.
.
COPYRIGHT 2000 The Center for AIDS: Hope & Remembrance Project
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Research Initiative/Treatment Action!
Date:Mar 1, 2000
Words:363
Previous Article:LETTER FROM THE EDITOR.
Next Article:ZIDOVUDINE (Retrovir).
Topics:



Related Articles
New Fact Sheets.(Citizens for Midwifery offer fact sheets on midwifery and natural childbirth)
Strategic Approaches to Clandestine Drug Laboratory Enforcement.(Brief Article)
AIDS Treatment Fact Sheets: Interview with Bob Munk, New Mexico AIDS InfoNet.
Juvenile Justice.(Brief Article)
For teachers only. (Resources/Answer Key).(sources of information about drug use)
Drugs and crime. (Bulletin Reports).(Brief Article)
Fact sheet on structured treatment interruption.(Fact Sheet)
Tip helps unravel homicide in 1995.(Crime)(A Springfield woman and her alleged accomplice confess)
Medicare HIV fact sheet: caution re January 2006.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles